Page 94 - BH-3-3

Brain & Heart Combination of EDN and RDN treatment

References catheter-based renal denervation in the absence of
antihypertensive medications (SPYRAL HTN-OFF MED
1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/ Pivotal): A multicentre, randomised, sham-controlled trial.
AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ Lancet. 2020;395:1444-1451.
PCNA guideline for the prevention, detection, evaluation,
and management of high blood pressure in adults: Executive doi: 10.1016/S0140-6736(20)30554-7
summary: A report of the American college of cardiology/ 9. Mahfoud F, Kandzari DE, Kario K, et al. Long-
American Heart Association task force on clinical practice term efficacy and safety of renal denervation in the
guidelines. Circulation. 2018;138:e426-e483. presence of antihypertensive drugs (SPYRAL HTN-ON
doi: 10.1161/CIR.0000000000000597 MED): A randomised, sham-controlled trial. Lancet.
2022;399:1401-1410.
2. Blood Pressure Lowering Treatment Trialists Collaboration.
Pharmacological blood pressure lowering for primary and doi: 10.1016/S0140-6736(22)00455-X
secondary prevention of cardiovascular disease across 10. Barbato E, Azizi M, Schmieder RE, et al. Renal
different levels of blood pressure: An individual participant- denervation in the management of hypertension in
level data meta-analysis. Lancet. 2021;397:1625-1636.
adults. A clinical consensus statement of the ESC
doi: 10.1016/S0140-6736(21)00590-0 council on hypertension and the European association of
percutaneous cardiovascular interventions (EAPCI). Eur
3. Blood Pressure Lowering Treatment Trialists Collaboration.
Age-stratified and blood-pressure-stratified effects of blood- Heart J. 2023;44:1313-1330.
pressure-lowering pharmacotherapy for the prevention of doi: 10.1093/eurheartj/ehad054
cardiovascular disease and death: An individual participant-
level data meta-analysis. Lancet. 2021;398:1053-1064. 11. Pan T, Li L, Wei Q, et al. Endovascular celiac denervation for
glycemic control in patients with type 2 diabetes mellitus.
doi: 10.1016/S0140-6736(21)01921-8 J Vasc Interv Radiol. 2021;32:1519.e2-1528.e2.
4. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure doi: 10.1016/j.jvir.2021.07.023
lowering for prevention of cardiovascular disease and
death: A systematic review and meta-analysis. Lancet. 12. Mobinizadeh M, Arabloo J, Hamouzadeh P, Akbari Sari A.
2016;387:957-967. A systematic review of the effectiveness of catheter
ablation NavX mapping system for treatment of the cardiac
doi: 10.1016/S0140-6736(15)01225-8 arrhythmia. Med J Islam Repub Iran. 2015;29:189.
5. Kario K, Hoshide S, Narita K, Okawara Y, Kanegae H, 13. Khongphatthanayothin A, Kosar E, Nademanee K.
Investigators n. Cardiovascular prognosis in drug-resistant Nonfluoroscopic three-dimensional mapping for
hypertension stratified by 24-hour ambulatory blood arrhythmia ablation: Tool or toy? J Cardiovasc Electrophysiol.
pressure: The JAMP study. Hypertension. 2021;78:1781-190. 2000;11:239-243.
doi: 10.1161/HYPERTENSIONAHA.121.18198 doi: 10.1111/j.1540-8167.2000.tb01792.x
6. Osborn JW, Tyshynsky R, Vulchanova L. Function of renal 14. Hindricks G, Weiner S, McElderry T, et al. Acute safety,
nerves in kidney physiology and pathophysiology. Annu Rev effectiveness, and real-world clinical usage of ultra-high
Physiol. 2021;83:429-450. density mapping for ablation of cardiac arrhythmias: Results
doi: 10.1146/annurev-physiol-031620-091656 of the TRUE HD study. Europace. 2019;21:655-661.
7. Schmieder RE. Renal denervation: Where do we stand and doi: 10.1093/europace/euy191
what is the relevance to the nephrologist? Nephrol Dial 15. Kawakami T, Saito N, Yamamoto K, et al. Zero-fluoroscopy
Transplant. 2022;37:638-644. ablation for cardiac arrhythmias: A single-center experience
doi: 10.1093/ndt/gfaa237 in Japan. J Arrhythm. 2021;37:1488-1496.
8. Bohm M, Kario K, Kandzari DE, et al. Efficacy of doi: 10.1002/joa3.12644

Volume 3 Issue 3 (2025) 6 doi: 10.36922/bh.5123